{
    "info": {
        "nct_id": "NCT02940483",
        "official_title": "Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle or Resection Cavity in Children With Recurrent Posterior Fossa Ependymoma: A Pilot Study",
        "inclusion_criteria": "* Diagnosis: Patients with histologically verified ependymoma, with recurrence or progression involving anywhere in the brain and/or spine. To be eligible, patients' disease must have originated in the posterior fossa of the brain.\n* Patient must have either measurable or evaluable tumor as assessed by MRI of the brain and total spine.\n* An implanted catheter in the fourth ventricle or posterior fossa tumor cavity attached to a ventricular access device or agreement to have one placed.\n* A minimum of 7 days between last dose of systemic chemotherapy and/or radiation therapy and first infusion of 5-Azacytidine into fourth ventricle.\n* Life expectancy of at least 12 weeks in the opinion of the PI\n* Lansky score of 50 or greater if ≤16 years of age or Karnofsky score of 50 or greater if > 16 years of age.\n* Existing neurological deficits must have been stable for a minimum of 1 week prior to study enrollment.\n* Patients must have recovered from the acute toxic effects of all prior anticancer chemotherapy\n* Adequate bone marrow function defined by peripheral absolute neutrophil count (ANC) ≥ 500/µL, platelet count ≥ 50,000/ µL (transfusion independent), and hemoglobin ≥9.0 gm/dL (may receive RBC transfusions)\n* Patient or patient's legal representative, parent(s), or guardian able to provide written informed consent.\nHealthy volunteers allowed\nMust have minimum age of 1 Year\nMust have maximum age of 21 Years",
        "exclusion_criteria": "* Enrolled in another treatment protocol\n* Has received another investigational or chemotherapy agent or radiation therapy within 7 days prior to 5-Azacytidine infusion into the fourth ventricle.\n* Evidence of untreated infection\n* Pregnant of lactating women",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Lansky score of 50 or greater if ≤16 years of age or Karnofsky score of 50 or greater if > 16 years of age.",
            "criterions": [
                {
                    "exact_snippets": "Lansky score of 50 or greater if ≤16 years of age",
                    "criterion": "Lansky score",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": "<=",
                                "value": 16,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "N/A"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Karnofsky score of 50 or greater if > 16 years of age",
                    "criterion": "Karnofsky score",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">",
                                "value": 16,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* An implanted catheter in the fourth ventricle or posterior fossa tumor cavity attached to a ventricular access device or agreement to have one placed.",
            "criterions": [
                {
                    "exact_snippets": "An implanted catheter in the fourth ventricle or posterior fossa tumor cavity attached to a ventricular access device",
                    "criterion": "implanted catheter",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "fourth ventricle",
                                "posterior fossa tumor cavity"
                            ]
                        },
                        {
                            "requirement_type": "attachment",
                            "expected_value": "ventricular access device"
                        }
                    ]
                },
                {
                    "exact_snippets": "agreement to have one placed",
                    "criterion": "agreement to have implanted catheter placed",
                    "requirements": [
                        {
                            "requirement_type": "agreement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis: Patients with histologically verified ependymoma, with recurrence or progression involving anywhere in the brain and/or spine. To be eligible, patients' disease must have originated in the posterior fossa of the brain.",
            "criterions": [
                {
                    "exact_snippets": "histologically verified ependymoma",
                    "criterion": "ependymoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "histological verification",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "recurrence or progression involving anywhere in the brain and/or spine",
                    "criterion": "disease recurrence or progression",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "brain",
                                "spine"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "disease must have originated in the posterior fossa of the brain",
                    "criterion": "disease origin location",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": "posterior fossa of the brain"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Life expectancy of at least 12 weeks in the opinion of the PI",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy of at least 12 weeks",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "in the opinion of the PI",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "assessment authority",
                            "expected_value": "principal investigator"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 1 Year",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 1 Year",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "Year"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patient must have either measurable or evaluable tumor as assessed by MRI of the brain and total spine.",
            "criterions": [
                {
                    "exact_snippets": "measurable or evaluable tumor",
                    "criterion": "tumor",
                    "requirements": [
                        {
                            "requirement_type": "measurability or evaluability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "as assessed by MRI of the brain and total spine",
                    "criterion": "tumor assessment method",
                    "requirements": [
                        {
                            "requirement_type": "assessment method",
                            "expected_value": [
                                "MRI of the brain",
                                "MRI of the total spine"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Existing neurological deficits must have been stable for a minimum of 1 week prior to study enrollment.",
            "criterions": [
                {
                    "exact_snippets": "Existing neurological deficits must have been stable for a minimum of 1 week prior to study enrollment.",
                    "criterion": "neurological deficits",
                    "requirements": [
                        {
                            "requirement_type": "stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "week"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patient or patient's legal representative, parent(s), or guardian able to provide written informed consent.",
            "criterions": [
                {
                    "exact_snippets": "Patient or patient's legal representative, parent(s), or guardian able to provide written informed consent.",
                    "criterion": "ability to provide written informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A minimum of 7 days between last dose of systemic chemotherapy and/or radiation therapy and first infusion of 5-Azacytidine into fourth ventricle.",
            "criterions": [
                {
                    "exact_snippets": "A minimum of 7 days between last dose of systemic chemotherapy ... first infusion of 5-Azacytidine into fourth ventricle",
                    "criterion": "interval between last dose of systemic chemotherapy and first infusion of 5-Azacytidine into fourth ventricle",
                    "requirements": [
                        {
                            "requirement_type": "minimum interval",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "A minimum of 7 days between last dose of ... radiation therapy and first infusion of 5-Azacytidine into fourth ventricle",
                    "criterion": "interval between last dose of radiation therapy and first infusion of 5-Azacytidine into fourth ventricle",
                    "requirements": [
                        {
                            "requirement_type": "minimum interval",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must have recovered from the acute toxic effects of all prior anticancer chemotherapy",
            "criterions": [
                {
                    "exact_snippets": "Patients must have recovered from the acute toxic effects of all prior anticancer chemotherapy",
                    "criterion": "acute toxic effects of prior anticancer chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "recovery",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 21 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 21 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 21,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate bone marrow function defined by peripheral absolute neutrophil count (ANC) ≥ 500/µL, platelet count ≥ 50,000/ µL (transfusion independent), and hemoglobin ≥9.0 gm/dL (may receive RBC transfusions)",
            "criterions": [
                {
                    "exact_snippets": "peripheral absolute neutrophil count (ANC) ≥ 500/µL",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 500,
                                "unit": "/µL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "platelet count ≥ 50,000/ µL (transfusion independent)",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50000,
                                "unit": "/µL"
                            }
                        },
                        {
                            "requirement_type": "transfusion independence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hemoglobin ≥9.0 gm/dL (may receive RBC transfusions)",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9.0,
                                "unit": "gm/dL"
                            }
                        },
                        {
                            "requirement_type": "RBC transfusions allowed",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Pregnant of lactating women",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "lactating women",
                    "criterion": "lactation status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Evidence of untreated infection",
            "criterions": [
                {
                    "exact_snippets": "Evidence of untreated infection",
                    "criterion": "untreated infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Enrolled in another treatment protocol",
            "criterions": [
                {
                    "exact_snippets": "Enrolled in another treatment protocol",
                    "criterion": "enrollment in another treatment protocol",
                    "requirements": [
                        {
                            "requirement_type": "enrollment status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has received another investigational or chemotherapy agent or radiation therapy within 7 days prior to 5-Azacytidine infusion into the fourth ventricle.",
            "criterions": [
                {
                    "exact_snippets": "Has received another investigational or chemotherapy agent ... within 7 days prior to 5-Azacytidine infusion into the fourth ventricle.",
                    "criterion": "receipt of another investigational or chemotherapy agent",
                    "requirements": [
                        {
                            "requirement_type": "time since last receipt",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Has received ... radiation therapy within 7 days prior to 5-Azacytidine infusion into the fourth ventricle.",
                    "criterion": "receipt of radiation therapy",
                    "requirements": [
                        {
                            "requirement_type": "time since last receipt",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}